Lessons from COVID-19 to increase opioid vaccine acceptance.

ABSTRACT: COVID-19 has put vaccine efficacy under a spotlight. However, the reluctance of people to be vaccinated has postponed the end of the COVID-19 pandemic. Currently, opioid vaccines are being developed, which could help prevent opioid addiction, overdoses, or relapse in combination with medication-assisted therapy. The fear is that the uptake of opioid vaccines could be met by the same reluctance as seen with COVID-19 vaccines.

SUBMITTER: Damiescu R 

PROVIDER: S-EPMC9448697 | biostudies-literature | 2022 Dec

REPOSITORIES: biostudies-literature